Efficacy of add-on adefovir dipivoxil at week 12/24 in HBeAg-positive chronic hepatitis B patients during PEG-IFNα therapy
ObjectiveTo investigate the efficacy of add-on adefovir dipivoxil (ADV) at week 12/24 in HBeAg-positive chronic hepatitis B (CHB) patients with hepatitis B virus (HBV) DNA levels of ≥105 copies/ml during pegylated interferonα (PEG-IFNα) therapy. MethodsA retrospective analysis was performed on 74 HB...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Journal of Clinical Hepatology
2016-04-01
|
| Series: | Linchuang Gandanbing Zazhi |
| Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=7296 |